ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway.

Jia Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.